SCHEMBL18558644

SCHEMBL18558644

CC(C)(C)N/C(=N/C(=O)c1ccc(C(F)(F)F)cc1)Nc1n[nH]c(C(C)(C)C)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.38
HDAC6 Q9UBN7 1/20 0.37
GSK3B P49841 2/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
MCHR1 Q99705 1/20 0.33
P2RY14 Q15391 1/20 0.33
MAP2K4 P45985 1/20 0.32
PRKAB2 O43741 1/20 0.32
PRKAG1 P54619 1/20 0.32
PRKAA2 P54646 1/20 0.32
PRKAA1 Q13131 1/20 0.32
PRKAG3 Q9UGI9 1/20 0.32
PRKAG2 Q9UGJ0 1/20 0.32
PRKAB1 Q9Y478 1/20 0.32
PDE2A O00408 1/20 0.32
JAK2 O60674 1/20 0.32
DHODH Q02127 1/20 0.32
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920889 0.84 HDAC6 (0.37) TRPV1HDAC6GSK3BMCHR1P2RY14
SCHEMBL18557806 0.82 ALOX15 (0.46) HDAC6
SCHEMBL18557800 0.80 P2RX7 (0.43)
SCHEMBL19976852 0.79 HDAC6 (0.40) TRPV1HDAC6GSK3B
SCHEMBL9921034 0.77 HDAC6 (0.39) TRPV1HDAC6GSK3BCES2CES1
SCHEMBL18558594 0.77 HDAC6 (0.39) TRPV1HDAC6GSK3BCES2CES1
SCHEMBL9905332 0.75 P2RY14 (0.38) TRPV1HDAC6CES2CES1P2RY14
SCHEMBL9905327 0.75 P2RY14 (0.38) TRPV1HDAC6CES2CES1P2RY14
SCHEMBL18558075 0.75 SNCA (0.37) TRPV1HDAC6P2RY14MAP2K4PRKAB2
SCHEMBL9920926 0.75 RAB9A (0.53) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580388-B2 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2017-02-28 US disclosed